D-Index & Metrics Best Publications

Yasushi Yatabe

Nagoya University
Japan

Medicine

Japan

2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 112 Citations 61,662 717 World Ranking 2920 National Ranking 55

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in Japan Leader Award

Overview

What is he best known for?

The fields of study Yasushi Yatabe is best known for:

Cancer
Gene
Immune system

His Internal medicine study frequently links to other fields, such as Proportional hazards model. His study in Malignant transformation extends to Pathology with its themes. Yasushi Yatabe combines Malignant transformation and Malignancy in his studies. His work often combines Malignancy and Atypia studies. His study deals with a combination of Atypia and Nuclear atypia. His Nuclear atypia study frequently links to related topics such as Immunohistochemistry. His work blends Immunohistochemistry and Pathology studies together. In his works, Yasushi Yatabe conducts interdisciplinary research on Cancer and Oncology. He integrates Oncology and Cancer in his studies.

His most cited work include:

BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer (327 citations)
The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities (316 citations)
Solitary fibrous tumour: significance of p53 and CD34 immunoreactivity in its malignant transformation (227 citations)

What are the main themes of his work throughout his whole career to date

As part of his studies on Internal medicine, Yasushi Yatabe often connects relevant areas like Chemotherapy. Yasushi Yatabe applies his multidisciplinary studies on Cancer and Epidermal growth factor receptor in his research. He integrates several fields in his works, including Pathology and Immunohistochemistry. Yasushi Yatabe conducted interdisciplinary study in his works that combined Immunohistochemistry and Pathology. In his works, he conducts interdisciplinary research on Genetics and Gene. His multidisciplinary approach integrates Gene and Genetics in his work. In his articles, he combines various disciplines, including Cancer research and Cancer. His research on Oncology often connects related areas such as Lung cancer. His research ties Oncology and Lung cancer together.

Yasushi Yatabe most often published in these fields:

Internal medicine (68.42%)
Cancer (52.63%)
Pathology (47.37%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

William D Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G Nicholson.
Journal of Thoracic Oncology (2011)

5144 Citations

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Tetsuya Mitsudomi;Satoshi Morita;Yasushi Yatabe;Shunichi Negoro.
Lancet Oncology (2010)

3358 Citations

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification

William D. Travis;Elisabeth Brambilla;Andrew G. Nicholson;Yasushi Yatabe.
Journal of Thoracic Oncology (2015)

3244 Citations

Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival

Junichi Takamizawa;Hiroyuki Konishi;Kiyoshi Yanagisawa;Shuta Tomida.
Cancer Research (2004)

3208 Citations

A Polycistronic MicroRNA Cluster, miR-17-92, Is Overexpressed in Human Lung Cancers and Enhances Cell Proliferation

Yoji Hayashita;Hirotaka Osada;Yoshio Tatematsu;Hideki Yamada.
Cancer Research (2005)

2030 Citations

Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer Biological and Clinical Implications

Takayuki Kosaka;Yasushi Yatabe;Hideki Endoh;Hiroyuki Kuwano.
Cancer Research (2004)

1503 Citations

Comprehensive genomic profiles of small cell lung cancer

Julie George;Jing Shan Lim;Se Jin Jang;Yupeng Cun.
Nature (2015)

1489 Citations

EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors

Young Lim Choi;Manabu Soda;Yoshihiro Yamashita;Toshihide Ueno.
The New England Journal of Medicine (2010)

1327 Citations

Increased Expression of Cyclooxygenase 2 Occurs Frequently in Human Lung Cancers, Specifically in Adenocarcinomas

Toyoaki Hida;Yasushi Yatabe;Hiroyuki Achiwa;Hideki Muramatsu.
Cancer Research (1998)

1151 Citations

Mutations of the Epidermal Growth Factor Receptor Gene Predict Prolonged Survival After Gefitinib Treatment in Patients With Non–Small-Cell Lung Cancer With Postoperative Recurrence

Tetsuya Mitsudomi;Takayuki Kosaka;Hideki Endoh;Yoshitsugu Horio.
Journal of Clinical Oncology (2005)

1014 Citations

If you think any of the details on this page are incorrect, let us know.